What is mVASC treatment?
The mVASC treatment has been widely applied to address microvascular insufficiencies in areas of discomfort like joints, tendons, and ligaments. By targeting these microvascular shortcomings and enhancing local circulation, mVASC can foster a more conducive healing environment for slow-to-recover musculoskeletal soft tissue injuries. This could alleviate pain and contribute to better clinical outcomes.
How does mVASC work?
There are cases where mVASC boosted blood flow in small vessels of tissues in various painful conditions, such as knee injuries, knee arthritis, shoulder injuries, foot inflammation, and nerve damage from diabetes. Small vessels are vital for most tissues because they carry oxygen and nutrients and remove waste. By improving small vessel function and blood flow, mVASC may enhance the healing process of hard-to-heal musculoskeletal injuries, reducing pain and improving clinical outcomes.
Is mVASC treatment safe?
mVASC is regulated by FDA (The Food and Drug Administration) as a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P), produced in accordance with FDA regulations for Good Tissue Practices. Product safety and quality has been the number one priority since its introduction in 2015.
What to expect after mVASC treatment?
Patients often see notable improvements in range of motion and pain reduction within 6-8 weeks of the procedure. With proper adherence to post-procedure care, many patients gradually return to their normal activities with relative ease. We have seen that mVASC improves local blood flow, reducing pain and enhancing healing in our patients after just a single treatment. Spine and Joint Center is excited to offer regenerative mVASC treatment in Hackensack NJ.